These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 537929)

  • 21. Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer.
    Nguyen NP; Ceizyk M; Vos P; Vinh-Hung V; Davis R; Desai A; Abraham D; Krafft SP; Jang S; Watchman CJ; Ewell L; Hamilton R; Smith-Raymond L
    Oral Oncol; 2010 Apr; 46(4):283-6. PubMed ID: 20188620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoma of the larynx. Results of radiation therapy in 213 patients.
    Goffinet DR; Eltringham JR; Glatstein E; Bagshaw MA
    Am J Roentgenol Radium Ther Nucl Med; 1973 Mar; 117(3):553-64. PubMed ID: 4693017
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of supraglottic cancer by radical high dose radiotherapy.
    Bataini JP; Ennuyer A; Poncet P; Ghossein NA
    Cancer; 1974 May; 33(5):1253-62. PubMed ID: 4207293
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pre-operative radiotherapy for N0 supraglottic carcinoma: a randomized study].
    Tang P; Zhang B; Xu G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):203-5. PubMed ID: 8745456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Computerized tomography in the evaluation of the larynx after surgical treatment and irradiation].
    Misiti A; Macori F; Caimi M; Palmeggiani F; Falchetto Osti M; Iacari V; Anaveri G
    Radiol Med; 1997 Dec; 94(6):600-6. PubMed ID: 9524596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation tolerance of the normal tissues of the larynx. Its implications in radiotherapy.
    Aristizabal SA; Caldwell WL
    Radiology; 1972 May; 103(2):419-22. PubMed ID: 5024571
    [No Abstract]   [Full Text] [Related]  

  • 27. Radical radiotherapy for T3 laryngeal cancers.
    Uno T; Itami J; Kotaka K; Toriyama M
    Strahlenther Onkol; 1996 Aug; 172(8):422-6. PubMed ID: 8765344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of radioisotope teletherapy of cancer of the larynx].
    Skołyszewski J; Reinfuss M; Kowalska T
    Nowotwory; 1988; 38(2):119-27. PubMed ID: 3226929
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship between lymph nodal status and primary tumor control probability in tumors of the supraglottic larynx.
    Wall TJ; Peters LJ; Brown BW; Oswald MJ; Milas L
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1895-902. PubMed ID: 4055449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
    Xie M; Sun Y; Li Y
    Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of cervical lymph node metastasis of 1400 patients with cancer of the larynx.
    Tomik J; Składzien J; Modrzejewski M
    Auris Nasus Larynx; 2001 Aug; 28(3):233-40. PubMed ID: 11489367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of radiation therapy in the treatment of supraglottic carcinoma.
    Deffebach RR; Phillips TL
    Cancer; 1972 Nov; 30(5):1159-63. PubMed ID: 5083055
    [No Abstract]   [Full Text] [Related]  

  • 33. [An attempt to evaluate prognosis in cases of metastasis from laryngeal and hypopharyngeal carcinoma to cervical lymph nodes].
    Sieczka JP
    Ann Acad Med Stetin; 1996; 42():157-76. PubMed ID: 9199119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracapsular spread of carcinoma in cervical lymph nodes. Impact upon survival in patients with carcinoma of the supraglottic larynx.
    Snyderman NL; Johnson JT; Schramm VL; Myers EN; Bedetti CD; Thearle P
    Cancer; 1985 Oct; 56(7):1597-9. PubMed ID: 4027895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control by irradiation alone of nonfixed clinically positive lymph nodes from squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx.
    Schneider JJ; Fletcher GH; Barkley HT
    Am J Roentgenol Radium Ther Nucl Med; 1975 Jan; 123(1):42-8. PubMed ID: 1119658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
    Eriksen JG; Steiniche T; Overgaard J;
    Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of repeated radiotherapy in patients with laryngeal cancer].
    Kholin VV; Bartova VF
    Med Radiol (Mosk); 1984 Jul; 29(7):23-7. PubMed ID: 6748883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma of the larynx.
    Robertson AG; Boyle P; Deuchars F; Robertson C
    J Surg Oncol; 1987 Aug; 35(4):217-22. PubMed ID: 3613590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of arytenoid edema following radiotherapy of laryngeal carcinoma with respect to residual and recurrent tumour.
    Ichimura K; Sugasawa M; Nibu K; Takasago E; Hasezawa K
    Auris Nasus Larynx; 1997 Oct; 24(4):391-7. PubMed ID: 9352832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.